In the dynamic landscape of healthcare, digital diagnostic tools have become a catalyst for transforming patient care, enabling accessibility and precision like never before. Among the trailblazing companies at the forefront of this revolution is TachMed, a European startup that is reshaping the future of healthcare through its innovative approach and advanced technologies.
TachMed recognizes the pivotal role of digital diagnostic tools in making healthcare accessible to all. By harnessing the power of telemedicine, remote monitoring, and artificial intelligence, TachMed is breaking down barriers and bridging the gap between patients and healthcare providers. Regardless of geographical location, patients can now access expert medical advice, receive timely diagnoses, and monitor their health remotely, ensuring that quality care is no longer limited by physical boundaries.
Moreover, TachMed’s commitment to precision in healthcare is unwavering. By leveraging sophisticated digital diagnostic tools, including AI-driven algorithms and data analytics, The company empowers healthcare professionals to make accurate and informed decisions. These tools enable comprehensive analysis of patient data, leading to precise diagnoses, tailored treatment plans, and improved patient outcomes.
As one of the 10 European startups shaking the future of healthcare in 2023, TachMed exemplifies the transformative power of digital diagnostic tools. By prioritizing accessibility and precision, TachMed is spearheading a new era of patient-centric care, where advanced technologies empower individuals to take control of their health, regardless of their location.
In an interview with Healthcare Everything, Paul Christie, the CEO of TachMed talks about how the company is reshaping the healthcare landscape and a future where accessibility and precision are the cornerstones of healthcare excellence.
Following are the excerpts from the interview:
Brief us about the company. What led to its inception?
Having started my career as an investment banker back in 1995, I’ve always considered myself somewhat entrepreneurial. In the early days, I sought to differentiate myself, moving away from trading just French Francs or German Deutsche Mark and exploring the South African Rand and other currencies.
In fact, it was whilst I was running a fund in Africa that the idea for Tachmed was born. Having examined the local community health provisions as part of our positive impact activities, I quickly realized that the health data in the World Health Organization (WHO) reports were several years out of date. This outdated information was included within community health epidemiology reports and would have severely distorted any policy decision-making and subsequent action taken on the ground– however, there wasn’t the technology available (at the right cost) to solve the problem.
This led me to question why we can’t have diagnostics that leverage advances in materials and digital technology connected to telehealth. These tools could then provide real-time data for clinicians and other organizations, all connected to the internet via a smartphone. Having assembled a team of leading scientists, engineers and clinicians, we are looking to launch our product to the market at the start of 2024—it’s been a really exciting journey.
Shed some light on your journey as the guiding light of the company. How does your presence play an important role in the growth of the company?
You are only as good as the team around you and as we all share the same philosophy and vision, we’ve all played an instrumental role in getting to this point. As anyone developing an ‘industry-first’ or something truly groundbreaking will understand, there can be high points and low points. I’ve always tried to keep the momentum going and remind the team of the impact our work will have.
Can you elaborate upon the core values, mission, and vision on which the company is built?
At Tachmed, we are determined to combine our aim for democratic, accessible and precise healthcare with the endless possibilities of digital technology. Digital diagnostics tools have immense potential and our vision is for the Tachmed device to be used not only by consumers within their own homes but also in primary care settings, on the frontline, to assist with better disaster relief efforts or in remote communities lacking healthcare infrastructure—the possibilities are endless.
How does your company offer personalized solutions to the target population? How will these solutions benefit the patients?
As Tachmed’s digital diagnostic device can be used frequently for a range of different diagnostics, the technology will also transform how those living with chronic health conditions manage their own health. This might be identifying certain symptoms earlier or taking preventative measures to ensure that their condition does not deteriorate.
What endeavors is the company currently pursuing to improve its measures and best serve patients?
From our perspective, bringing frontline diagnostics into people’s homes is exciting and will enable patients to be better served no matter where they live. Our smart devices act as the main point where information comes in and this data is then automatically processed and shared with relevant parties via machine learning (ML) and artificial intelligence (AI) technology.
The fact that the technology is providing a person with data about the state of their health in real-time will enable patients from all demographics to be better served. Once collated, the AI makes decisions based on the data, calculating what behavioral changes or therapeutics are required to improve that person’s health. If a prescription is required, the process can be automated. Essentially, you are getting a consultation with a doctor via a virtual front door.
What advice would you like to give to budding entrepreneurs and enthusiasts who desire to venture into the healthcare industry?
My first piece of advice would be that to bring about positive change you need a clear mindset, the pursuit of best practices, being prepared to challenge the status quo, and, of course, a great team. Combine these with a clear desire to change the world, enough time and funding and you are on the path to success.
How do you envision scaling your company’s services and operations in 2023 and beyond?
Following successful trials being conducted throughout 2023, we see the Tachmed device launching to the market at the start of 2024. Initially, we expect to see the biggest demand from private healthcare providers and insurers, however, the sky is the limit. We are also launching community outreach programs to embrace and realize our inclusive societal goals.